Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : SEC charges Florida man for insider trading of Mylan stock

09/17/2021 | 06:01pm EDT

NEW YORK (AP) — A former executive at pharmaceutical company Mylan has pleaded guilty to insider trading in the company’s securities, the Justice Department said Friday.

The department said Dayakar Mallu, 51, of Orlando, Florida, worked with another executive at Mylan to make trades between 2017 and 2019 based on nonpublic information about Mylan. The information ranged from corporate earnings, to new drug approvals, to Mylan's eventual merger with a division of Pfizer.

At the time, Mallu was Mylan’s vice president of global operations information technology. The Justice Department listed the other Mylan executive as an unnamed co-conspirator.

Mallu realized net profits and losses avoided of more than $4.2 million, the department said. He allegedly shared the trading profits with the other Mylan insider through payments routed through India. He also he sent false information to his tax preparer, the Justice Department said.

Mallu is scheduled to be sentenced in January and faces a maximum 25 years for the insider trading and three years for the tax offense. He also consented to charges from the Securities and Exchange Commission that, if approved by a judge, would bar him from acting as the officer or director of a public company.

Mylan merged in late 2020 with Pfizer division Upjohn to form a new drug company known as Viatris.

Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

All news about PFIZER, INC.
03:56pMODERNA : U.S. administers 407.4 mln doses of COVID-19 vaccines -CDC
RE
10/15PFIZER : States can reserve COVID-19 shots for younger kids next week
AQ
10/15FDA panel recommends J&J COVID-19 booster for all recipients who got first shot
AQ
10/15MODERNA : COVID SCIENCE-Statins may slightly lower COVID-19 death risk; using a different ..
RE
10/15PFIZER : FDA panel endorses booster shot for J&J COVID-19 vaccine
AQ
10/15MODERNA : U.S. FDA delays decision on Moderna's COVID-19 vaccine for adolescents - WSJ
RE
10/15PFIZER : FDA panel takes up tough questions on J&J COVID-19 boosters
AQ
10/15MODERNA : U.S. FDA advisers to vote on J&J COVID-19 vaccine booster
RE
10/15THE LATEST : Pfizer seeks European OK for child vaccines
AQ
10/15PFIZER : BioNTech ask EU agency to OK vaccine for kids 5-11
AQ
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 101 M - -
Net income 2021 18 457 M - -
Net Debt 2021 29 308 M - -
P/E ratio 2021 12,3x
Yield 2021 3,80%
Capitalization 233 B 233 B -
EV / Sales 2021 3,23x
EV / Sales 2022 3,68x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 41,49 $
Average target price 45,72 $
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.13.20%232 621
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283